Friday 6 November 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.

Revenue: +8.28%
EPS: +36.7%
Free cash flow: +19.1%
Total debt: +44.9%

Quarter to September 2026, against a year earlier

S&P 500

229.99 3.65 +1.61%

Follow DHR

Alert me

Market cap: $159.2B
P/E: 37.0×
Fwd P/E: 36.9×
Dividend yield: 0.67%
F-score: 6/9
Altman Z: 4.52
Beneish M: −2.57
Dividend safety: 69/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Danaher Corporation 8-K filed Oct 13, 2026

Period ended Oct 9, 2026 · Filed Oct 13, 2026 · accepted 8:53 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 8.01 Other events

Red flags

Officer departure Oct 13, 2026
Danaher Corporation reported the departure of its Chief Financial Officer

8-K filed Oct 13, 2026 · The filing · sec.gov